Christoph Ortland
Founder and CEO, FD CRO
Key Points
- Navigating regulatory compliance for small sponsors
- Scaling processes to meet evolving requirements
- Effective risk management and vendor oversight strategies
- Supporting quality assurance in small-scale operations
- The critical role of electronic tools in trial management
Tom interviews Christoph Ortland, Founder and CEO of FD CRO, to discuss the unique challenges small sponsors face and how boutique CROs can provide tailored solutions to meet industry standards. Christoph shares invaluable insights on regulatory compliance, quality management, risk mitigation, and the growing importance of digital tools in clinical trial oversight.
Chapters
About the Guest
Christoph Ortland
Founder and CEO, FD CRO
Christoph Ortland, CEO and Founder of FD CRO, has been a key contributor in clinical development since 1993 and leads Forschungsdock CRO with a focus on precision, quality, and people-centered project management.
His experience as a GCP auditor, trainer, and consultant has made him a trusted partner for small sponsors navigating complex regulatory requirements and risk management.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.